Smoking-associated DNA methylation biomarkers and their predictive value for all-cause and cardiovascular mortality

Environmental Health Perspectives

Volumn 124, Issue 1, 2016, Pages 67-74

  Zhang, Yan ^a   Schöttker, Ben ^a   Florath, Ines ^a   Stock, Christian ^b   Butterbach, Katja ^a   Holleczek, Bernd ^c   Mons, Ute ^a   Brenner, Hermann ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c SAARLAND CANCER REGISTRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; DNA METHYLATION; DOSE RESPONSE; FEMALE; FOLLOW UP; GENE MAPPING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK ASSESSMENT; SMOKING; ADVERSE EFFECTS; BLOOD; CARDIOVASCULAR DISEASE; DRUG EFFECTS; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL;

BIOLOGICAL MARKER;

AGED; BIOMARKERS; CARDIOVASCULAR DISEASES; DNA METHYLATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SMOKING;

EID: 84952663150     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1409020     Document Type: Article

References (48)

1. Benner A, Zucknick M, Hielscher T, Ittrich C, Mansmann U. 2010. High-dimensional Cox models: the choice of penalty as part of the model building process. Biom J 52:50–69.
2. Breitling LP, Salzmann K, Rothenbacher D, Burwinkel B, Brenner H. 2012. Smoking, F2RL3 methylation, and prognosis in stable coronary heart disease. Eur Heart J 33:2841–2848.
3. CDC (Centers for Disease Control and Prevention). 2010. How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking- Attributable Disease: A Report of the Surgeon General. Atlanta, GA:CDC. Available: http://www.ncbi.nlm.nih.gov/books/NBK53017/[accessed 11 May 2015].
4. CDC. 2014. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. Atlanta, GA:CDC. Available: http://www.ncbi.nlm.nih.gov/books/NBK179276/[accessed 11 May 2015].
5. Connor Gorber S, Schofield-Hurwitz S, Hardt J, Levasseur G, Tremblay M. 2009. The accuracy of self-reported smoking: a systematic review of the relationship between self-reported and cotinine-assessed smoking status. Nicotine Tob Res 11:12–24.
6. Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al. 2003. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 24:987–1003.
7. Cook NR. 2007. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 115:928–935.
8. Cook NR. 2010. Methods for evaluating novel biomarkers–a new paradigm. Int J Clin Pract 64:1723–1727.
9. Decramer M, Janssens W, Miravitlles M. 2012. Chronic obstructive pulmonary disease. Lancet 379:1341–1351.
10. Desquilbet L, Mariotti F. 2010. Dose-response analyses using restricted cubic spline functions in public health research. Stat Med 29:1037–1057.
11. Ezzati M, Henley SJ, Lopez AD, Thun MJ. 2005a. Role of smoking in global and regional cancer epide-miology: current patterns and data needs. Int J Cancer 116:963–971.
12. Ezzati M, Henley SJ, Thun MJ, Lopez AD. 2005b. Role of smoking in global and regional cardiovascular mortality. Circulation 112:489–497.
13. Goeman JJ. 2010. L1 penalized estimation in the Cox proportional hazards model. Biom J 52:70–84.
14. Goeman JJ, Meijer R, Chaturvedi N. 2014. Package ‘penalized’. Available: https://cran.r-project.org/web/packages/penalized/index.html.
15. Haarmann-Stemmann T, Bothe H, Kohli A, Sydlik U, Abel J, Fritsche E. 2007. Analysis of the transcrip-tional regulation and molecular function of the aryl hydrocarbon receptor repressor in human cell lines. Drug Metab Dispos 35:2262–2269.
16. Harrell FE Jr, Lee KL, Mark DB. 1996. Multivariable prog-nostic models: issues in developing models, evalu-ating assumptions and adequacy, and measuring and reducing errors. Stat Med 15:361–387.
17. Joubert BR, Håberg SE, Nilsen RM, Wang X, Vollset SE, Murphy SK, et al. 2012. 450K epigenome-wide scan identifies differential DNA methylation in newborns related to maternal smoking during pregnancy. Environ Health Perspect 120:1425–1431; doi:10.1289/ehp.1205412.
18. Kasai A, Hiramatsu N, Hayakawa K, Yao J, Maeda S, Kitamura M. 2006. High levels of dioxin-like poten-tial in cigarette smoke evidenced by in vitro and in vivo biosensing. Cancer Res 66:7143–7150.
19. Kramer A, Jansen AC, van Aalst-Cohen ES, Tanck MW, Kastelein JJ, Zwinderman AH. 2006. Relative risk for cardiovascular atherosclerotic events after smoking cessation: 6–9 years excess risk in indi-viduals with familial hypercholesterolemia. BMC Public Health 6:262; doi:10.1186/1471-2458-6-262.
20. Leger AJ, Covic L, Kuliopulos A. 2006. Protease-activated receptors in cardiovascular diseases. Circulation 114:1070–1077.
21. Leone A. 2007. Smoking, haemostatic factors, and cardiovascular risk. Curr Pharm Des 13:1661–1667.
22. Lightwood JM, Glantz SA. 1997. Short-term economic and health benefits of smoking cessation: myo cardial infarction and stroke. Circulation 96:1089–1096.
23. Lin DY, Wei LJ, Ying ZL. 1993. Checking the Cox model with cumulative sums of martingale-based residuals. Biometrika 80:557–572.
24. Lodovici M, Bigagli E. 2009. Biomarkers of induced active and passive smoking damage. Int J Environ Res Public Health 6:874–888.
25. Löw M, Stegmaier C, Ziegler H, Rothenbacher D, Brenner H, ESTHER study. 2004. Epidemiological investigations of the chances of preventing, recog-nizing early and optimally treating chronic diseases in an elderly population (ESTHER study) [in German]. Dtsch Med Wochenschr 129:2643–2647.
26. Manini P, De Palma G, Andreoli R, Goldoni M, Poli D, Lasagni G, et al. 2003. Urinary excretion of 4-vinyl phenol after experimental and occupational exposure to styrene [in Italian]. G Ital Med Lav Ergon 25(suppl 3):61–62.
27. Martey CA, Baglole CJ, Gasiewicz TA, Sime PJ, Phipps RP. 2005. The aryl hydrocarbon receptor is a regulator of cigarette smoke induction of the cyclooxygenase and prostaglandin pathways in human lung fibroblasts. Am J Physiol Lung Cell Mol Physiol 289:L391–L399.
28. May S, Hosmer DW. 2004. A cautionary note on the use of the Grønnesby and Borgan goodness-of- fit test for the Cox proportional hazards model. Lifetime Data Anal 10:283–291.
29. Meek MD, Finch GL. 1999. Diluted mainstream ciga-rette smoke condensates activate estrogen receptor and aryl hydrocarbon receptor-mediated gene transcription. Environ Res 80:9–17.
30. Melander O, Newton-Cheh C, Almgren P, Hedblad B, Berglund G, Engström G, et al. 2009. Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA 302:49–57.
31. ® Global Forum 2013 Conference. Cary, NC:SAS Institute Inc. Available: http://support.sas.com/resources/papers/proceedings13/504-2013.pdf [accessed 11 May 2015].
32. Miller SA, Dykes DD, Polesky HF. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215; doi:10.1093/nar/16.3.1215.
33. Mimura J, Ema M, Sogawa K, Fujii-Kuriyama Y. 1999. Identification of a novel mechanism of regula-tion of Ah (dioxin) receptor function. Genes Dev 13:20–25.
34. Moennikes O, Loeppen S, Buchmann A, Andersson P, Ittrich C, Poellinger L, et al. 2004. A constitutively active dioxin/aryl hydrocarbon receptor promotes hepatocarcinogenesis in mice. Cancer Res 64:4707–4710.
35. Monick MM, Beach SR, Plume J, Sears R, Gerrard M, Brody GH, et al. 2012. Coordinated changes in AHRR methylation in lymphoblasts and pulmonary macrophages from smokers. Am J Med Genet B Neuropsychiatr Genet 159B:141–151.
36. Pencina MJ, D’Agostino RB Sr., D’Agostino RB Jr., Vasan RS. 2008. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27:157–172.
37. Petersen AK, Zeilinger S, Kastenmüller G, Römisch- Margl W, Brugger M, Peters A, et al. 2014. Epigenetics meets metabolomics: an epigenome- wide association study with blood serum meta-bolic traits. Hum Mol Genet 23:534–545.
38. Pot C. 2012. Aryl hydrocarbon receptor controls regulatory CD4+ T cell function. Swiss Med Wkly 142:w13592; doi:10.4414/smw.2012.13592.
39. Rahman MM, Laher I. 2007. Structural and functional alteration of blood vessels caused by cigarette smoking: an overview of molecular mechanisms. Curr Vasc Pharmacol 5:276–292.
40. Rebagliato M. 2002. Validation of self reported smoking [Editorial]. J Epidemiol Community Health 56:163–164.
41. Schöttker B, Herder C, Rothenbacher D, Roden M, Kolb H, Müller H, et al. 2013a. Proinflammatory cytokines, adiponectin, and increased risk of primary cardiovascular events in diabetic patients with or without renal dysfunction: results from the ESTHER study. Diabetes Care 36:1703–1711.
42. Schöttker B, Müller H, Rothenbacher D, Brenner H. 2013b. Fasting plasma glucose and HbA(1c) in cardiovascular risk prediction: a sex-specific comparison in individuals without diabetes mellitus. Diabetologia 56:92–100.
43. Shenker NS, Polidoro S, van Veldhoven K, Sacerdote C, Ricceri F, Birrell MA, et al. 2013a. Epigenome-wide association study in the European Prospective Investigation into Cancer and Nutrition (EPIC-Turin) identifies novel genetic loci associated with smoking. Hum Mol Genet 22:843–851.
44. Shenker NS, Ueland PM, Polidoro S, van Veldhoven K, Ricceri F, Brown R, et al. 2013b. DNA methylation as a long-term biomarker of exposure to tobacco smoke. Epidemiology 24:712–716.
45. Wang TJ, Gona P, Larson MG, Tofler GH, Levy D, Newton-Cheh C, et al. 2006. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 355:2631–2639.
46. Zeilinger S, Kühnel B, Klopp N, Baurecht H, Kleinschmidt A, Gieger C, et al. 2013. Tobacco smoking leads to extensive genome-wide changes in DNA methylation. PLoS One 8:e63812; doi:10.1371/journal.pone.0063812.
47. Zhang Y, Yang R, Burwinkel B, Breitling LP, Brenner H. 2014. F2RL3 methylation as a biomarker of current and lifetime smoking exposures. Environ Health Perspect 122:131–137; doi:10.1289/ehp.1306937.
48. Zudaire E, Cuesta N, Murty V, Woodson K, Adams L, Gonzalez N, et al. 2008. The aryl hydrocarbon receptor repressor is a putative tumor suppressor gene in multiple human cancers. J Clin Invest 118:640–650.